Abstract
ObjectivesTo evaluate (i) the association between random certolizumab drug levels, antidrug antibodies (ADAbs) and treatment response in patients with rheumatoid arthritis (RA); (ii) longitudinal factors associated with ADAbs and certolizumab...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have